United States · FDA National Drug Code directory
HEPLISAV-B
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83703-048_53e7f6a9-93df-5233-e063-6394a90ae22d
- Product NDC
- 83703-048
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Hepatitis B Vaccine (Recombinant) Adjuvanted
- Labeler
- Bamboo US BidCo LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20180101
- Source listing expiry
- 20271231
Source-listed ingredients
- HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN — 20 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 SYRINGE in 1 CARTON (83703-048-05) / .5 mL in 1 SYRINGE (83703-048-01) · 83703-048-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →